GO
Loading...

Arena Pharmaceuticals CEO on Belviq

Tuesday, 11 Jun 2013 | 5:40 PM ET

Arena Pharmaceuticals' new obesity drug Belviq hits the U.S. shelves today. Lonnel Coats, Eisai CEO, and Jack Lief, Arena CEO, discuss expectations for the drug.